Career Enhancement Program
职业提升计划
基本信息
- 批准号:10005302
- 负责人:
- 金额:$ 6.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-22 至 2022-08-31
- 项目状态:已结题
- 来源:
- 关键词:AdvocacyAmerican Association of Cancer ResearchAmerican Society of Clinical OncologyAwardBasic ScienceBudgetsCancer BiologyCancer CenterCancer Research ProjectClinicalClinical ResearchCollaborationsDevelopmentDevelopment PlansDiagnosisDiseaseDoctor of MedicineEarly DiagnosisEarly treatmentEnsureFacultyFosteringFoundationsFundingGoalsGrantHealthcareInstitutionInternationalInterventionLaboratoriesLeadershipMalignant neoplasm of ovaryManuscriptsMentorsMentorshipMinorityMonitorMorbidity - disease rateNanotechnologyOvarianPaperPatientsPeer ReviewPreventionPublishingResearchResearch PersonnelResourcesScientistTexasTrainingTranslatingTranslational ResearchUnited States National Institutes of HealthWomanWorkWritinganticancer researchbasebench to bedsidecancer diagnosiscareercareer developmentclinical caredesignexperienceimprovedinnovationinvestigator trainingmeetingsmembermortalitynext generationnovelprogramsrecruitrole modelsuccesssupportive environmentsymposiumtranslational approach
项目摘要
Career Enhancement Program SUMMARY/ABSTRACT
The central goal of the Career Enhancement Program (CEP) is to use the resources at MD Anderson to train
exceptional young investigators who will reduce the morbidity and mortality from ovarian cancer through
making advances in the early detection, prevention, and treatment of this disease. To achieve this goal, the
SPORE CEP will provide two awards, each of $50,000 annually for two years, funded from the SPORE and
matching funds from MD Anderson. The intent of each CEP award is to prepare the selected scientists to
become international leaders in academic research relevant to ovarian cancer. We will achieve this by
aggressive recruitment of the most promising young investigators and the institution of an individualized
development plan with clinical and a laboratory mentors and a mentoring committee, formal course work,
coaching in grant and paper writing, leadership training, attendance at national meetings, networking with
ovarian cancer scholars and completing and publishing a translational ovarian cancer research program.
During our past SPORE awards, the CEP has developed the careers of 21 young investigators. In the first year
of the original grant, three postdoctoral trainees received CE awards, and of the 18 faculty members supported
since 2000, all have remained in academic research and 13 are engaged predominantly in ovarian cancer
research. Ten have achieved peer-reviewed funding and two additional awardees have received competitive
foundation grants. The six awardees in the most recently funded cycle received one R01, one R03, two CPRIT
awards, two Texas Center for Nanotechnology Grants, one Liz Tilberis Scholar Award from the Ovarian
Cancer Research Fund and one Susan Poorman Blackie Ovarian Cancer grant. After entering the program,
awardees have published over 500 peer-reviewed papers regarding ovarian cancer. Of the faculty awardees,
five are project leaders, co-investigators, collaborators or core leaders on the current SPORE (Drs. Anil Sood,
Jinsong Liu, KK Wong, Vikas Kundra, and Guang Peng). Moving forward, the CEP will be led by Dr. Anil Sood,
who is an outstanding role model and most effective mentor.
职业提升计划摘要/摘要
职业提升计划 (CEP) 的中心目标是利用 MD 安德森的资源来培训
杰出的年轻研究人员将通过以下方式降低卵巢癌的发病率和死亡率
在这种疾病的早期发现、预防和治疗方面取得了进展。为了实现这一目标,
SPORE CEP 将提供两项奖励,两年内每年各 50,000 美元,资金来自 SPORE 和
MD 安德森的配套资金。每个 CEP 奖项的目的是让选定的科学家做好准备
成为卵巢癌相关学术研究的国际领导者。我们将通过以下方式实现这一目标
积极招募最有前途的年轻研究人员并建立个性化的研究团队
与临床和实验室导师以及指导委员会的发展计划,正式课程作业,
资助金和论文写作指导、领导力培训、参加全国会议、与人建立联系
卵巢癌学者完成并出版了转化性卵巢癌研究计划。
在过去的 SPORE 奖项中,CEP 培养了 21 名年轻研究人员的职业生涯。第一年
在最初的资助中,三名博士后培训生获得了 CE 奖,在 18 名教职人员中获得了资助
自 2000 年以来,所有人都继续从事学术研究,其中 13 人主要从事卵巢癌研究
研究。十人获得了同行评审资助,另外两名获奖者获得了竞争性资助
基金会补助金。最近资助周期的六名获奖者获得了一项 R01、一项 R03、两项 CPRIT
奖,两项德克萨斯纳米技术中心资助,一项来自卵巢的 Liz Tilberis 学者奖
癌症研究基金和一项 Susan Poorman Blackie 卵巢癌补助金。进入程序后,
获奖者发表了 500 多篇有关卵巢癌的同行评审论文。在获奖教师中,
五位是当前 SPORE 的项目领导者、联合研究员、合作者或核心领导者(Anil Sood 博士、
刘劲松、KK Wong、Vikas Kundra 和彭光)。展望未来,CEP 将由 Anil Sood 博士领导,
他是杰出的榜样和最有效的导师。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANIL K SOOD其他文献
ANIL K SOOD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANIL K SOOD', 18)}}的其他基金
Harnessing the power of exosomes for non-coding RNA delivery
利用外泌体的力量进行非编码 RNA 递送
- 批准号:
9754614 - 财政年份:2017
- 资助金额:
$ 6.87万 - 项目类别:
Harnessing the power of exosomes for non-coding RNA delivery
利用外泌体的力量进行非编码 RNA 递送
- 批准号:
9979631 - 财政年份:2017
- 资助金额:
$ 6.87万 - 项目类别:
Harnessing the power of exosomes for non-coding RNA delivery
利用外泌体的力量进行非编码 RNA 递送
- 批准号:
9388779 - 财政年份:2017
- 资助金额:
$ 6.87万 - 项目类别:
Harnessing the power of exosomes for non-coding RNA delivery
利用外泌体的力量进行非编码 RNA 递送
- 批准号:
10670211 - 财政年份:2017
- 资助金额:
$ 6.87万 - 项目类别:
Project 3: The Role of Macrophages in Resistance to Anti-VEGF Drugs in Ovarian Cancer
项目3:巨噬细胞在卵巢癌抗VEGF药物耐药中的作用
- 批准号:
10005297 - 财政年份:2017
- 资助金额:
$ 6.87万 - 项目类别:
Project 3: The Role of Macrophages in Resistance to Anti-VEGF Drugs in Ovarian Cancer
项目3:巨噬细胞在卵巢癌抗VEGF药物耐药中的作用
- 批准号:
10251116 - 财政年份:2017
- 资助金额:
$ 6.87万 - 项目类别: